Komori
Occurring Fact4886ASKA Pharmaceutical Holdings Co.,Ltd.Pharmaceuticals

Notice concerning the change of certified public accountants and other auditors

The Company has decided to change its accounting auditor from 清陽監査法人 to EY ShinNihon LLC and will submit a proposal for the appointment of the new auditor at the Annual General Meeting of Shareholders scheduled for 24 June 2026. Subject to shareholder approval, the change is scheduled to take effect on the same date.

Worth reading
26Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Change of Certified Public Accountants, etc.

Subject Entity

ASKA Pharmaceutical Holdings Co.,Ltd.

Occurrence24 June 2026 (scheduled to take effect upon the conclusion of the 5th Annual General Meeting of Shareholders)
This disclosure05/25/2026
Cause

The Company determined that an audit from a new perspective could be expected, taking into account the length of the continuous audit engagement and the business policy of the Group's global expansion.

Outlook

The Company will submit the proposal entitled "Election of Accounting Auditor" to the 5th Annual General Meeting of Shareholders scheduled to be held on 24 June 2026. 清陽監査法人's term of office will expire upon the conclusion of that meeting, and subject to approval, EY ShinNihon LLC is scheduled to take office.

Event that occurred
ItemDetails
Event nameChange of Certified Public Accountants, etc.
Date of occurrence24 June 2026 (scheduled to take effect upon the conclusion of the 5th Annual General Meeting of Shareholders)
Subject EntityASKA Pharmaceutical Holdings Co.,Ltd.
CauseThe Company determined that an audit from a new perspective could be expected, taking into account the length of the continuous audit engagement and the business policy of the Group's global expansion.
OutlookThe Company will submit the proposal entitled "Election of Accounting Auditor" to the 5th Annual General Meeting of Shareholders scheduled to be held on 24 June 2026. 清陽監査法人's term of office will expire upon the conclusion of that meeting, and subject to approval, EY ShinNihon LLC is scheduled to take office.
Items this document does not state (20)
Date recognized / date notice receivedTarget Locations / ProductsAmount of Impact on Business PerformanceAccounting period in which recognizedImpact on Earnings ForecastType of litigation or proceedingCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceDirectors' and officers' liabilityVoting rights ownership percentage before the changeVoting rights ownership percentage after the changePlanned follow-up disclosure

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Although the current audit is being conducted appropriately and properly, the Company comprehensively considered the length of the continuous audit engagement, the Group's global expansion, the expected benefits of an audit from a new perspective, standardization of the audit structure, and expertise, independence and quality control systems. As a result, it determined that EY ShinNihon LLC was the appropriate choice.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice concerning the change of certified public accountants and other auditors | ASKA Pharmaceutical Holdings Co.,Ltd. (4886) timely disclosure | Komori